Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Spatomics is a private spatial biology tools company developing high-plex in situ protein and RNA analysis solutions for research use. Its core technology, Cleavable Fluorescent Probe (CFP), uses cleavable tyramide fluorophores and cyclic staining/imaging workflows to enable sensitive multiplex spatial profiling in FFPE and fresh frozen tissue with off-the-shelf antibodies. The company offers assays, reagents, panels, staining services, and automation-oriented workflows intended to generate subcellular spatial omics data. Spatomics is positioned as a life science tools and platform company rather than a therapeutic drug developer, with applications spanning oncology, immunology, neuroscience, and infectious disease research. The company has also partnered with service and reagent providers to expand adoption of its spatial multiomics workflows.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Spatomics.